Navigation Links
Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
Date:8/6/2013

SAN DIEGO, Aug. 6, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's Senior Vice President and Chief Commercial Officer Scott Byrd will present the company's corporate overview on Tuesday, August 13, 2013 at 12:45pm Eastern Time (9:45am Pacific Time) during the 2013 Wedbush PacGrow Life Sciences Management Access Conference at Le Parker Meridien Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section.  A replay of the webcast will be available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Contacts:

William R. LaRue

SVP, CFO                                      

Cadence Pharmaceuticals, Inc.

858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
3. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
5. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
6. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
7. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
8. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
10. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
11. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... -- According to market research "Global Computed Tomography ... 2022 - Industry Insights by Slice Type (High, Mid and ... P&S Market Research, the global computed tomography market ... expected to grow at a CAGR of 5.0% during 2016-2022. ... expected to witness the faster growth, CAGR of 5.3%, during ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... Research and Markets has ... Myeloid Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights 2016, provides comprehensive insights ... Myeloid Leukemia epidemiology, Acute Myeloid Leukemia market ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... ... CURE Media Group , the nation’s leading digital and print media ... Angels to expand outreach and emotional support for patients of all ages battling ... lifeline to patients and families facing the challenges of cancer diagnosis and treatment,” said ...
(Date:5/5/2016)... ... May 05, 2016 , ... If you don’t mind a bit ... skin, you may want to consider a treatment that some have called the next ... P.C. , Microneedling, also known as skin needling, is a procedure using a ...
(Date:5/5/2016)... ... ... Dermatologic surgeons performed nearly 10 million medically necessary and cosmetic procedures in ... The results of the 2015 ASDS Survey on Dermatologic Procedures released today reveal a ... growing popularity of soft-tissue fillers and body sculpting procedures. , For the fourth ...
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health Management, LLC, ... that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By becoming a ... their patients being treated for substance use. , Enlightened Solutions was founded by ...
(Date:5/5/2016)... GA (PRWEB) , ... May 05, 2016 , ... Liposuction ... (FDRS) 2016 Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. ... Byrd was chosen to address the conference about her unique specialization in treating Lipedema. ...
Breaking Medicine News(10 mins):